These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18559603)

  • 1. Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme.
    Lazovic J; Jensen MC; Ferkassian E; Aguilar B; Raubitschek A; Jacobs RE
    Clin Cancer Res; 2008 Jun; 14(12):3832-9. PubMed ID: 18559603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.
    Kahlon KS; Brown C; Cooper LJ; Raubitschek A; Forman SJ; Jensen MC
    Cancer Res; 2004 Dec; 64(24):9160-6. PubMed ID: 15604287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study.
    Kim K; Gwak HS; Han N; Hong EK; Choi BK; Lee S; Choi S; Park JH; Seok JH; Jeon Y; Cho H; Lee SJ; Lee Y; Nam KT; Song SW
    Front Immunol; 2021; 12():715000. PubMed ID: 34819930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
    Hegde M; Corder A; Chow KK; Mukherjee M; Ashoori A; Kew Y; Zhang YJ; Baskin DS; Merchant FA; Brawley VS; Byrd TT; Krebs S; Wu MF; Liu H; Heslop HE; Gottschalk S; Yvon E; Ahmed N
    Mol Ther; 2013 Nov; 21(11):2087-101. PubMed ID: 23939024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma.
    Brown CE; Badie B; Barish ME; Weng L; Ostberg JR; Chang WC; Naranjo A; Starr R; Wagner J; Wright C; Zhai Y; Bading JR; Ressler JA; Portnow J; D'Apuzzo M; Forman SJ; Jensen MC
    Clin Cancer Res; 2015 Sep; 21(18):4062-72. PubMed ID: 26059190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastomas expressing IL13Ralpha2 are targets for IL13-zetakine+ cytolytic T cells.
    Stastny MJ; Brown CE; Ruel C; Jensen MC
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):669-77. PubMed ID: 17921847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrodin synergistically increases migration of interleukin-13 receptor α2 chimeric antigen receptor T cell to the brain against glioblastoma multiforme: A preclinical study.
    Huang S; Bai Y; An Z; Xu C; Zhang C; Wang F; Zhong C; Zhong X
    Phytother Res; 2023 Dec; 37(12):5947-5957. PubMed ID: 37748098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells.
    Brown CE; Starr R; Aguilar B; Shami AF; Martinez C; D'Apuzzo M; Barish ME; Forman SJ; Jensen MC
    Clin Cancer Res; 2012 Apr; 18(8):2199-209. PubMed ID: 22407828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
    Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
    Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma.
    Yaghoubi SS; Jensen MC; Satyamurthy N; Budhiraja S; Paik D; Czernin J; Gambhir SS
    Nat Clin Pract Oncol; 2009 Jan; 6(1):53-8. PubMed ID: 19015650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI.
    Arbab AS; Janic B; Jafari-Khouzani K; Iskander AS; Kumar S; Varma NR; Knight RA; Soltanian-Zadeh H; Brown SL; Frank JA
    PLoS One; 2010 Feb; 5(2):e9365. PubMed ID: 20195476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.
    Shimato S; Natsume A; Wakabayashi T; Tsujimura K; Nakahara N; Ishii J; Ito M; Akatsuka Y; Kuzushima K; Yoshida J
    J Neurosurg; 2008 Jul; 109(1):117-22. PubMed ID: 18590440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing effect of interleukin-13 receptor alpha 2 (IL-13Ralpha2) sensitized DC-CTL cells on human glioblastoma U251 cells.
    Yan X; Su Z; Zhang J; Wu Z; Ye S; Lu X; Wu J; Zeng Y; Zheng W
    Cell Immunol; 2010; 263(2):172-5. PubMed ID: 20400066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.
    Pituch KC; Miska J; Krenciute G; Panek WK; Li G; Rodriguez-Cruz T; Wu M; Han Y; Lesniak MS; Gottschalk S; Balyasnikova IV
    Mol Ther; 2018 Apr; 26(4):986-995. PubMed ID: 29503195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.
    Brown CE; Aguilar B; Starr R; Yang X; Chang WC; Weng L; Chang B; Sarkissian A; Brito A; Sanchez JF; Ostberg JR; D'Apuzzo M; Badie B; Barish ME; Forman SJ
    Mol Ther; 2018 Jan; 26(1):31-44. PubMed ID: 29103912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.
    Allen C; Paraskevakou G; Iankov I; Giannini C; Schroeder M; Sarkaria J; Schroeder M; Puri RK; Russell SJ; Galanis E
    Mol Ther; 2008 Sep; 16(9):1556-64. PubMed ID: 18665158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.
    Krenciute G; Prinzing BL; Yi Z; Wu MF; Liu H; Dotti G; Balyasnikova IV; Gottschalk S
    Cancer Immunol Res; 2017 Jul; 5(7):571-581. PubMed ID: 28550091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cytotoxic T lymphocytes specific to malignant glioma using T2 cells pulsed with HLA-A2-restricted interleukin-13 receptor alpha 2 peptide in vitro.
    Jiang X; Lu X; Liu R; Zhang F; Zhao H
    Acta Biochim Biophys Sin (Shanghai); 2007 Sep; 39(9):641-8. PubMed ID: 17805458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
    Ahmed N; Salsman VS; Kew Y; Shaffer D; Powell S; Zhang YJ; Grossman RG; Heslop HE; Gottschalk S
    Clin Cancer Res; 2010 Jan; 16(2):474-85. PubMed ID: 20068073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy.
    Shimamura T; Fujisawa T; Husain SR; Joshi B; Puri RK
    Clin Cancer Res; 2010 Jan; 16(2):577-86. PubMed ID: 20068108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.